Pharma brands that fail to evolve risk losing relevance in a world where patients demand more control, transparency, and ...

San Diego, CA This invite-only summit, taking place at the luxurious Town and Country Resort in San Diego, CA, is designed ...

Over a month into Robert F. Kennedy Jr.’s tenure as HHS Secretary, leaders in pharma, medical marketing and media circles are preparing for a potential TV pharma ad ban.

This is an issue that global marketing and strategy leaders need to address. Many pharma and life sciences firms still approach global activity as they did 10 years ago; defining global ...

PE Hub rounded up five pharma marketing deals from the last five months, starting with the most recently announced. (We have ...

Today, any pharma marketing strategy has to take into account the perspective of multiple stakeholders, such as doctors, regulators, payers and the patient. Here, we speak with Dr Simone Seiter ...

Heather Gervais, CEO of Osso VR, discusses how technological advancements in VR are solving problems for pharmaceutical sales ...

Lytgobi is an FGFR inhibitor that received accelerated approval in 2022 to treat adults with previously treated, unresectable ...

In the complex pharmaceutical market, achieving high levels of brand memorability directly influences patient choices and adherence, making it a critical focus for marketing strategies.

And Catalyst Pharmaceuticals stock is one of those that seems to be thriving. Catalyst is Thursday's selection for IBD 50 ...

How is AI playing a role in our society today, especially when it comes to content creation in pharma as well as other ...

Highlighting deals by PE firms pursuing investments in marketing agencies focused on pharma and life sciences; insights on a ...